Patents Represented by Attorney, Agent or Law Firm Jeremy K. McKown
  • Patent number: 7365062
    Abstract: The invention is directed to nonpeptide substituted benzodiazepines of Formula I, wherein A, X, n, R1, R2, R3, R4, R5, a and b are as described in the specification, which are useful as vasopressin receptor antagonists for treating conditions associated with vasopressin receptor activity such as those involving increased vascular resistance and cardiac insufficiency. Pharmaceutical compositions comprising a compound of Formula I and methods of treating conditions such as hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis, or water retention are also disclosed.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: April 29, 2008
    Assignee: Ortho McNeil Pharmaceutical, Inc.
    Inventors: Robert H. K. Chen, Min A. Xiang
  • Patent number: 6492354
    Abstract: A solid mixture or aqueous solution of amoxicillin antibacterial agent with a material that aids in its dissolution in water to render it ingestive and palatable.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: December 10, 2002
    Assignee: Pharmaceutical Solutions, Inc.
    Inventors: Michael Strobel, Pat Soderlund
  • Patent number: 6410543
    Abstract: A palatable antimicrobial drug concentrate comprising: (a) a sulfonamide and/or sulfonamide salt in aqueous solution; (b) a 2,4-diaminopyrimidine in stable suspension within said solution; and (c) a suspending agent. The invention has a long room temperature shelf life and is sufficiently stable to be administered via the drinking water of animals.
    Type: Grant
    Filed: February 12, 2001
    Date of Patent: June 25, 2002
    Assignee: Pharmaceutical Solutions, Inc.
    Inventors: Michael A. Strobel, William A. Soderlund, Jr.